Rangnekar VM - Search Results

1

Nicotinic modulation of therapeutic response in vitro and in vivo.

Warren GW, Romano MA, Kudrimoti MR, Randall ME, McGarry RC, Singh AK, Rangnekar VM. Warren GW, et al. Among authors: rangnekar vm. Int J Cancer. 2012 Dec 1;131(11):2519-27. doi: 10.1002/ijc.27556. Epub 2012 Apr 16. Int J Cancer. 2012. PMID: 22447412 Free article.

2

The phosphoinositide 3-kinase/Akt1/Par-4 axis: a cancer-selective therapeutic target.

Goswami A, Ranganathan P, Rangnekar VM. Goswami A, et al. Among authors: rangnekar vm. Cancer Res. 2006 Mar 15;66(6):2889-92. doi: 10.1158/0008-5472.CAN-05-4458. Cancer Res. 2006. PMID: 16540633 Review.

3

The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.

Sun Y, St Clair DK, Fang F, Warren GW, Rangnekar VM, Crooks PA, St Clair WH. Sun Y, et al. Among authors: rangnekar vm. Mol Cancer Ther. 2007 Sep;6(9):2477-86. doi: 10.1158/1535-7163.MCT-07-0186. Mol Cancer Ther. 2007. PMID: 17876045 Free PMC article.

4

Accuracy of self-reported tobacco assessments in a head and neck cancer treatment population.

Warren GW, Arnold SM, Valentino JP, Gal TJ, Hyland AJ, Singh AK, Rangnekar VM, Cummings KM, Marshall JR, Kudrimoti MR. Warren GW, et al. Among authors: rangnekar vm. Radiother Oncol. 2012 Apr;103(1):45-8. doi: 10.1016/j.radonc.2011.11.003. Epub 2011 Nov 25. Radiother Oncol. 2012. PMID: 22119370 Free PMC article.

5

A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors.

Hebbar N, Burikhanov R, Shukla N, Qiu S, Zhao Y, Elenitoba-Johnson KSJ, Rangnekar VM. Hebbar N, et al. Among authors: rangnekar vm. Cancer Res. 2017 Aug 1;77(15):4039-4050. doi: 10.1158/0008-5472.CAN-16-1970. Epub 2017 Jun 16. Cancer Res. 2017. PMID: 28625975 Free PMC article.

6

Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression.

Chakraborty M, Qiu SG, Vasudevan KM, Rangnekar VM. Chakraborty M, et al. Among authors: rangnekar vm. Cancer Res. 2001 Oct 1;61(19):7255-63. Cancer Res. 2001. PMID: 11585763

7

Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis.

Azmi AS, Wang Z, Burikhanov R, Rangnekar VM, Wang G, Chen J, Wang S, Sarkar FH, Mohammad RM. Azmi AS, et al. Among authors: rangnekar vm. Mol Cancer Ther. 2008 Sep;7(9):2884-93. doi: 10.1158/1535-7163.MCT-08-0438. Mol Cancer Ther. 2008. PMID: 18790769 Free PMC article.

8

Systemic Par-4 inhibits non-autochthonous tumor growth.

Zhao Y, Burikhanov R, Brandon J, Qiu S, Shelton BJ, Spear B, Bondada S, Bryson S, Rangnekar VM. Zhao Y, et al. Among authors: rangnekar vm. Cancer Biol Ther. 2011 Jul 15;12(2):152-7. doi: 10.4161/cbt.12.2.15734. Epub 2011 Jul 15. Cancer Biol Ther. 2011. PMID: 21613819 Free PMC article.

9

Novel mechanism of apoptosis resistance in cancer mediated by extracellular PAR-4.

Burikhanov R, Shrestha-Bhattarai T, Qiu S, Shukla N, Hebbar N, Lele SM, Horbinski C, Rangnekar VM. Burikhanov R, et al. Among authors: rangnekar vm. Cancer Res. 2013 Jan 15;73(2):1011-9. doi: 10.1158/0008-5472.CAN-12-3212. Epub 2012 Nov 30. Cancer Res. 2013. PMID: 23204231 Free PMC article.

10

Apoptosis and tumor resistance conferred by Par-4.

Zhao Y, Rangnekar VM. Zhao Y, et al. Among authors: rangnekar vm. Cancer Biol Ther. 2008 Dec;7(12):1867-74. doi: 10.4161/cbt.7.12.6945. Epub 2008 Dec 8. Cancer Biol Ther. 2008. PMID: 18836307 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page